Johnson & Johnson
Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therap…
What to know about JNJ
Johnson & Johnson is a Healthcare company with a mixed financial profile. It scores well on size and risk, but valuation is worth keeping an eye on.
Should you consider JNJ?
Based on 31 financial metrics and sector comparison. Not financial advice.
-
Johnson & Johnson is a Healthcare company with a mixed overall financial profile — it sits in the upper half of Healthcare stocks (19 of 59).
-
The business is both profitable and financially healthy — it keeps a good portion of what it earns and carries its debt comfortably.
-
Valuation is in the middle of the pack — neither obviously cheap nor stretched.
-
Growth has been slower than most peers. That's not necessarily a dealbreaker, but it means the investment case rests more on current earnings than future expansion.
-
This stock pays no dividend — your return depends entirely on the share price rising over time.
-
Risk is relatively low — the stock tends to be less volatile than the broader market, which typically means a smoother ride during uncertain periods.
-
This is a mixed picture — real strengths in some areas, but areas that need watching too. Do your homework on the sector before deciding.
At a glance
How it scores
We look at 31 different financial metrics and group them into categories. Here's how JNJ compares to the other S&P 500 stocks.
Dive deeper — all 31 metrics 9 categories · valuation, growth, health, dividends & more Show all Hide
Valuation
Is the stock cheap or expensive relative to its earnings, sales, and assets? Lower multiples often mean better value.
| Metric | Value | vs S&P 500 |
|---|---|---|
| P/E Ratio (Trailing) | 26.46 | Average |
| Forward P/E | 17.96 | Average |
| PEG Ratio | 3.06 | Below avg |
| Price to Sales | 5.71 | Average |
| Price to Book | 6.77 | Average |
| EV/EBITDA | 17.45 | Average |
| Earnings Yield | 3.78% | Average |
Profitability
How efficiently does the company turn revenue into profit? Higher margins mean more money kept from each dollar earned.
| Metric | Value | vs S&P 500 |
|---|---|---|
| Gross Margin | 68.04% | Top 25% |
| Operating Margin | 27.41% | Above avg |
| Net Profit Margin | 21.83% | Top 25% |
| Return on Equity | 26.42% | Above avg |
| Return on Invested Capital | 8.42% | Above avg |
Growth
How fast is the business expanding? Strong growth in revenue and earnings signals increasing market demand.
| Metric | Value | vs S&P 500 |
|---|---|---|
| Revenue Growth (YoY) | 9.90% | Above avg |
| Revenue Growth (3Y CAGR) | 5.60% | Above avg |
| EPS Growth (YoY) | -52.90% | Below avg |
| Free Cash Flow Growth | 6.94% | Above avg |
Health
Can the company cover its debts and obligations? A healthy balance sheet reduces the risk of financial trouble.
| Metric | Value | vs S&P 500 |
|---|---|---|
| Current Ratio | 1.02 | Average |
| Debt to Equity | 0.68 | Above avg |
| Interest Coverage | 34.55 | Top 25% |
| Altman Z-Score | — | N/A |
Dividends
Does the company pay shareholders, and is that payment growing and sustainable?
| Metric | Value | vs S&P 500 |
|---|---|---|
| Dividend Yield | — | N/A |
| Payout Ratio | — | N/A |
| Dividend Growth (5Y) | -8.82% | Average |
Cash Flow
Is real cash flowing into the business — not just accounting profits? Strong cash flow funds growth and dividends.
| Metric | Value | vs S&P 500 |
|---|---|---|
| Free Cash Flow Yield | 3.17% | Average |
| OCF to Sales | 23.73% | Above avg |
Risk
How volatile is the stock compared to the broader market? Lower beta and volatility mean a smoother ride.
| Metric | Value | vs S&P 500 |
|---|---|---|
| Beta (1-Year) | 0.26 | Top 25% |
| Volatility (30-Day) | 21.05% | Top 25% |
Sentiment
What do analysts and short-sellers think? High analyst ratings and low short interest signal broad confidence.
| Metric | Value | vs S&P 500 |
|---|---|---|
| Short % of Float | 1.08% | Top 25% |
| Avg. Analyst Rating | 2.00 | Above avg |
| Target Upside % | 10.72% | Average |
Size
How large is the company by market value? Size affects stability, growth potential, and index inclusion.
| Metric | Value | vs S&P 500 |
|---|---|---|
| Market Capitalization | 549.78B | Top 25% |
How does JNJ compare to…?
Pick another stock and see them side by side in seconds.
You might also look at
Companies in a similar position to JNJ — based on their financial profile.